Mink TherapeuticsINKT
13F holders, Q4 2025 (December 31)24holders +6
5new positions
0sold out
1famous investor
$11.15avg. 13F price*
At the end of Q4 2025, 24 institutions reported holding Mink Therapeutics Inc. (INKT) in their 13F filings, up 6 from Q3 2025. 5 opened new positions and 0 sold out. The largest holders were Vanguard Group Inc. ($754K), DRW Securities, LLC ($286K) and Longbow Finance SA ($186K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Mink Therapeutics Inc.
- CUSIP
- 603693201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $290K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 65,684 shares bought and 4,945 shares sold, net +60,739 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Vanguard Group Inc. | 0.00% | Add +102.8% | 67,651 | $754K |
| DRW Securities, LLC | 0.02% | New | 25,677 | $286K |
| Longbow Finance SA | 0.03% | No change | 16,667 | $186K |
| Geode Capital Management, LLC | 0.00% | Add +11.3% | 14,247 | $159K |
| Renaissance Technologies | 0.00% | Reduce -28.8% | 10,400 | $116K |
| UBS Group AG | 0.00% | Add +69.0% | 9,548 | $106K |
| BlackRock, Inc. | 0.00% | Reduce -1.5% | 6,203 | $69K |
| Paladin Partners, LLC | 0.01% | — | 1,000 | $11K |
| Bank of America Corp. | 0.00% | No change | 568 | $6K |
| Citigroup Inc. | 0.00% | New | 337 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -68.1% | 295 | $3K |
| Osaic Holdings, Inc. | 0.00% | Reduce -5.7% | 117 | $1K |
| Morgan Stanley | 0.00% | Reduce -9.6% | 104 | $1K |
| Covestor Ltd | 0.00% | No change | 131 | $1K |
| Wells Fargo & Company | 0.00% | New | 20 | $223 |
| Northwestern Mutual Wealth Management Co. | 0.00% | Reduce -5.3% | 18 | $201 |
| Game Plan Financial Advisors, LLC | 0.00% | No change | 16 | $178 |
| BNP Paribas Financial Markets | 0.00% | No change | 16 | $178 |
| Clearstead Advisors, LLC | 0.00% | No change | 14 | $157 |
| JPMorgan Chase & Co. | 0.00% | No change | 9 | $100 |
| Pinnacle Wealth Planning Services, Inc. | 0.00% | New | 5 | $56 |
| Barclays PLC | 0.00% | New | 4 | $45 |
| Key Financial Inc | 0.00% | No change | 4 | $45 |
| Jones Financial Companies LLLP | 0.00% | No change | 1 | $11 |
"% of holder's portfolio" is INKT's weight in each manager's 13F, not the share of Mink Therapeutics Inc. the manager owns.